α-Syrtuclein, Parkinson's disease, and Alzheimer's disease

被引:54
|
作者
Kim, SH [1 ]
Seo, JH [1 ]
Suh, YH [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Ctr Res Neurosci,Dept Pharmacol, MRC,Natl Creat Res Initiat Ctr Alzheimers Dementi, Seoul 110799, South Korea
关键词
alpha-synuclein; Parkinson's disease; Alzheimer's disease; neurodegeneration; neuroprotection;
D O I
10.1016/j.parkreldis.2003.11.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alpha synuclein (alpha-SN) is a ubiquitous protein that is especially abundant in the brain and has been postulated to play a central role in the pathogenesis of Parkinson's disease (PD), Alzheimer's disease, and other neurodegenerative disorders. Here, we show that alpha-SN plays dual role of neuroprotection and neurotoxicity depending on its concentration or level of expression. In addition, our study shows that alpha-synuclein is differentially expressed in human peripheral blood mononuclear cells. PD patients expressed more alpha-synuclein than healthy controls. Thus, the alpha-synuclein expression in the peripheral immune system might be one of the primary causes of immune abnormalities in PD patients. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S9 / S13
页数:5
相关论文
共 50 条
  • [31] Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease
    Li, Yanwei
    Zhao, Jinying
    Holscher, Christian
    [J]. CNS DRUGS, 2017, 31 (08) : 639 - 652
  • [32] Neuroinflammation in early stages of Alzheimer's disease and Parkinson's disease
    Eikelenboom, Piet
    Crosswell, A.
    van Engen, C.
    Limper, M.
    Hoozemans, J. J. M.
    Veerhuis, R.
    van Gool, W. A.
    Rozemuller, J. M.
    [J]. ADVANCES IN ALZHEIMER'S AND PARKINSON'S DISEASE: INSIGHTS, PROGRESS, AND PERSPECTIVES, 2008, 57 : 113 - 121
  • [33] MicroRNAs in the pathophysiology of Alzheimer’s disease and Parkinson's disease: an overview
    Mohammad Rafi Khezri
    Keyvan Yousefi
    Naime Majidi Zolbanin
    Morteza Ghasemnejad-Berenji
    [J]. Molecular Neurobiology, 2022, 59 : 1589 - 1603
  • [34] Lysosomal dysfunction in Alzheimer's disease and Parkinson disease
    Connolly, Owen M.
    Wahdan, Malak
    Deivasigamani, Senthilkumar
    Modi, Souvik
    [J]. MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 28 - 28
  • [35] Obstructive sleep apnea and the risk of Alzheimer's disease and Parkinson disease: A Mendelian randomization study OSA Alzheimer's disease and Parkinson disease ,
    Li, Jinwei
    Zhao, Lanqing
    Ding, Xiaoxu
    Cui, Xiangguo
    Qi, Li
    Chen, Yu
    [J]. SLEEP MEDICINE, 2022, 97 : 55 - 63
  • [36] Editorial: Highlights in Alzheimer's and Parkinson's disease
    Cantone, Mariagiovanna
    Sacco, Leonardo
    [J]. FRONTIERS IN HUMAN NEUROSCIENCE, 2023, 17
  • [37] Alzheimer's and Parkinson's disease therapies in the clinic
    Chopade, Puja
    Chopade, Neha
    Zhao, Zongmin
    Mitragotri, Samir
    Liao, Rick
    Suja, Vineeth Chandran
    [J]. BIOENGINEERING & TRANSLATIONAL MEDICINE, 2023, 8 (01)
  • [38] Genetic networks in Parkinson's and Alzheimer's disease
    Kelly, Jack
    Moyeed, Rana
    Carroll, Camille
    Luo, Shouqing
    Li, Xinzhong
    [J]. AGING-US, 2020, 12 (06): : 5221 - 5243
  • [39] Nanomedicine against Alzheimer's and Parkinson's Disease
    Tandon, Ankit
    Singh, Sangh J.
    Chaturvedi, Rajnish K.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (12) : 1507 - 1545
  • [40] Apathy in Alzheimer's and Parkinson's disease.
    Geldmacher, DS
    Sperry, SD
    Strauss, ME
    Whitney, C
    Riley, D
    [J]. GERONTOLOGIST, 2001, 41 : 281 - 281